CXCR4 and plasma cell myeloma: As we previously reported [27], intravenous injection of RPMI8226-CXCR4 cells results in their preferential BM localization and development of disease with features consistent with those of MM in human patients, including the patchy pattern of distribution, with foci of human myeloma cells surrounded by adjacent murine BM tissue.